Market Closed - Nyse 04:00:02 2024-12-10 pm EST 5-day change 1st Jan Change
83.58 USD -0.45% Intraday chart for Medtronic plc -2.49% +1.46%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017. Nov. 26 CI
InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors Nov. 25 CI
Barclays Adjusts Price Target on Medtronic to $109 From $105 Nov. 25 MT
Medtronic plc acquired Fortimedix Surgical B.V. Nov. 20 CI
UBS Raises Price Target on Medtronic to $93 From $90, Maintains Neutral Rating Nov. 20 MT
Medtronic Receives US FDA Clearance for InPen app Nov. 20 MT
Medtronic Says FDA Clears InPen App, Clearing Path for Glucose Monitoring System Launch Nov. 20 DJ
Medtronic plc Receives FDA Clearance for New Inpen App, Pending the Way for Its Smart MDI System Launch with Simplera?? CGM Nov. 20 CI
Global markets live: Alphabet, Nvidia, Tesla, Nestlé, ThyssenKrupp... Nov. 19Our Logo
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday Nov. 19 MT
Putin's nuclear playbook pivot panics the markets Nov. 19Our Logo
Medtronic plc, Q2 2025 Earnings Call, Nov 19, 2024 Nov. 19
Medtronic: annual targets further tightened Nov. 19 CF
Medtronic Narrows Fiscal Year Guidance as 2Q Tops Views Nov. 19 DJ
Futures Retreat Amid New Russia-Ukraine Tensions; Asia Gains, Europe Down Nov. 19 MT
Medtronic's Fiscal Q2 Non-GAAP Earnings, Revenue Rise; Fiscal 2025 Outlook Revised Nov. 19 MT
Medtronic lifts annual profit view on strong demand for medical devices Nov. 19 RE
Earnings Flash (MDT) MEDTRONIC Reports Fiscal Q2 Revenue $8.40B, vs. Street Est of $8.28B Nov. 19 MT
Earnings Flash (MDT) MEDTRONIC Posts Fiscal Q2 EPS $1.26, vs. Street Est of $1.25 Nov. 19 MT
Medtronic plc Reports Earnings Results for the Second Quarter and Six Months Ended October 25, 2024 Nov. 19 CI
European Midday Briefing : Stocks Pressured by Reports of Russian Nuclear Doctrine Change Nov. 19 DJ
Equities Close Mixed Ahead of Key Corporate Earnings Nov. 18 MT
Equities Close Mixed Ahead of Week's Key Corporate Earnings Nov. 18 MT
US Equities Markets End Mixed Monday Ahead of Major Corporate Earnings Nov. 18 MT
Equities Mixed as Investors Await This Week's Corporate Earnings Nov. 18 MT
Chart Medtronic plc
MDT: Dynamic Chart
Logo Medtronic plc
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (26%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.5%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (18%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - cranial and spinal technologies (14.7%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (9%); - diabetes management (7.7%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.4%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ; - other (0.7%). Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Employees
95,000
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
surperformance-ratings-light-chart MEDTRONIC-PLCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
83.58USD
Average target price
96.43USD
Spread / Average Target
+15.37%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MDT Stock
  4. News Medtronic plc
  5. Baird Cuts Price Target on Medtronic to $82 From $87, Maintains Neutral Rating